HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improved grading of breast adenocarcinomas based on genomic instability.

Abstract
Numerous investigations have shown that in primary breast adenocarcinomas DNA aneuploidy in contrast to DNA diploidy indicates high malignancy potential. On the basis of the study of 104 breast carcinomas, we describe a subtype of aneuploidy, which demonstrates a low degree of malignancy. In image cytometric DNA histograms, this subtype possessed a low percentage (< or = 8.8%) of nonmodal DNA values as measured by the stemline scatter index (SSI), which is defined as sum of the percentage of cells in the S-phase region, the G(2) exceeding rate and the coefficient of variation of the tumor stemline. The cut point of SSI = 8.8% (P = 0.03) enabled us to also subdivide diploid and tetraploid tumors into clinically low and high malignant variants. One possible reason for aneuploidy is impaired distribution of chromosomes at mitosis caused by numerical or structural centrosome aberrations. Cyclins A and E seem to be involved in centrosome duplication. Real-time quantitative PCR measurements of cyclin A and E transcript levels and immunohistochemical determination of cyclin A protein expression showed statistically significantly increased values in the tumors with a high SSI (>8.8%), compared with those with a low SSI. A pilot study demonstrated centrosomal aberrations in an average of 9.6% of the measured cells in four aneuploid carcinomas with high SSI values and in an average of 2.5% of the cells in three aneuploid and three diploid tumors with low SSI. Our data indicate that the SSI, most likely reflecting the degree of genomic instability, allows additional classifying of the known aneuploid, diploid, and tetraploid categories of primary breast adenocarcinomas into low and high malignant subtypes.
AuthorsUlrike Kronenwett, Sören Huwendiek, Carin Ostring, Neil Portwood, Uwe J Roblick, Yudi Pawitan, Ayodele Alaiya, Roland Sennerstam, Anders Zetterberg, Gert Auer
JournalCancer research (Cancer Res) Vol. 64 Issue 3 Pg. 904-9 (Feb 01 2004) ISSN: 0008-5472 [Print] United States
PMID14871819 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cyclin A
  • Cyclin E
  • DNA, Neoplasm
  • RNA, Messenger
Topics
  • Adenocarcinoma (genetics, pathology)
  • Adult
  • Aged
  • Aged, 80 and over
  • Breast Neoplasms (genetics, pathology)
  • Cell Nucleus (genetics, metabolism)
  • Centrosome (physiology)
  • Cyclin A (genetics)
  • Cyclin E (genetics)
  • DNA, Neoplasm (metabolism)
  • Female
  • Genomic Instability (genetics)
  • Humans
  • Middle Aged
  • Neoplasm Staging
  • Ploidies
  • RNA, Messenger (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: